van der Schoot, Gabriela G. F.
Ormel, Harm L.
Westerink, Nico-Derk L.
Wempe, Johan B.
Lefrandt, Joop D.
May, Anne M.
Vrieling, Aline H.
Meijer, Coby
Gietema, Jourik A.
Walenkamp, Annemiek M. E.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Physical exercise in patients with testicular cancer treated with bleomycin, etoposide and cisplatin chemotherapy: pulmonary and vascular endothelial function—an exploratory analysis
https://doi.org/10.1007/s00432-023-05469-5
Funding for this research was provided by:
KWF Kankerbestrijding (DCS 2011-5265, DCS 2011-5265, DCS 2011-5265, DCS 2011-5265)
Graduate School of Medical Sciences, University of Groningen
Article History
Received: 21 July 2023
Accepted: 9 October 2023
First Online: 27 October 2023
Declarations
:
: The authors declare the following financial interest/personal relationships which may be considered as potential competing interests: dr. A.M.E. Walenkamp: Grant: Dutch Cancer Society (inst). Research funding: Abbvie (inst), BMS (inst), Genzyme (inst), Karyopharm Therapeutics (inst), Roche (inst). Consulting of advisory role: Polyphor (inst), IPSEN (inst), Karyopharm (inst), Novartis (inst). Prof. Dr. J.A. Gietema: Research funding: Abbvie (inst), Roche (inst), Siemens (inst). No other potential conflicts of interest are reported by any of the authors.
: Written informed consent was obtained from all patients.